Helix BioPharma Corp. Announces Fiscal Third Quarter 2017 Results
TORONTO, ONTARIO--(Marketwired - Jun 13, 2017) - Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment …